This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Merz Aesthetics has extended its starry marketing strategy, signing up Salma Hay...
In this edition of STAT's AI Prognosis newsletter: A peek at STAT's Generative A...
QRD Appendix V - Adverse-drug-reaction reporting details
Human medicines European public assessment report (EPAR): Bavencio, avelumab, Da...
Recommendations on eligibility to PRIME scheme - Adopted at the CHMP meeting of ...
Human medicines European public assessment report (EPAR): Competact, pioglitazon...
And other biotech news stories, brought to you by The Readout.
AdvaMed and other healthcare groups have pleaded for the Trump administration to...
President Trump said his administration will soon impose tariffs on pharmaceutic...
Good morning. Yesterday, there was a turkey (or, as one reporter guessed, a turk...
DHL Group is earmarking 2 billion euros ($2.2 billion) to bulk up its healthcare...
Amended Biologics Working Party Vaccines Quality Operational Expert Group (BV-OE...
Human medicines European public assessment report (EPAR): Vyloy, Zolbetuximab, D...
Human medicines European public assessment report (EPAR): Besremi, ropeginterfer...
Human medicines European public assessment report (EPAR): Ronapreve, casirivimab...
Human medicines European public assessment report (EPAR): Talmanco (previously T...
Human medicines European public assessment report (EPAR): Fintepla, fenfluramine...
With two attempts to merge with other companies having collapsed, Vincerx Pharma...
Human medicines European public assessment report (EPAR): Ixchiq, Chikungunya va...
Merz Aesthetics has extended its starry marketing strategy, signing up Salma Hay...
Human medicines European public assessment report (EPAR): Opdivo, nivolumab, Dat...
Minutes of the PRAC meeting 28-31 October 2024
After another solid year that included 12% growth in the top line, Vertex has bu...
Minutes of the PRAC meeting 2-5 September 2024